Jane Street
ONCY

Jane Street’s Oncolytics Biotech ONCY Stock Holding History

Jane Street’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,400
Closed -$43.3K – 12687
2026
Q1 		$43.3K Buy
42,400
+28,685
+209% +$28.5K ﹤0.01% 11019
2025
Q4 		$14.2K Sell
13,715
-6,615
-33% -$7.15K ﹤0.01% 10784
2025
Q3 		$20.7K Hold
20,330
– – ﹤0.01% 10528
2025
Q2 		$15.5K Buy
+20,330
New +$10.8K ﹤0.01% 9380
2024
Q3 		– Sell
-12,728
Closed -$12.6K – 10165
2024
Q2 		$12.6K Buy
+12,728
New +$13.9K ﹤0.01% 9082
2020
Q1 		– Sell
-14,519
Closed -$69K – 5785
2019
Q4 		$69K Buy
+14,519
New +$16.4K ﹤0.01% 4880

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Jane Street's ONCY Position: Q2 2026 in Review

Jane Street sold out of Oncolytics Biotech (ONCY) in Q2 2026, closing a stake of 42,400 shares — an estimated $43.3K sold.

Jane Street first reported a position in ONCY in Q4 2019 and held it in 6 quarters. The position peaked at $69K in Q4 2019. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Jane Street reported no remaining Oncolytics Biotech position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 42,400 Oncolytics Biotech shares in Q2 2026, an estimated $43.3K.
  • Jane Street first reported a position in Oncolytics Biotech in Q4 2019 and held it in 6 quarters.
  • Jane Street's Oncolytics Biotech position peaked at $69K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.